Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER): Results of a 6-week, randomized, placebo-controlled study

doi:10.1016/j.schres.2007.03.003

Paper

Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER): Results of a 6-week, randomized, placebo-controlled study

Published Jul 1, 2007 · M. Davidson, R. Emsley, M. Kramer

Schizophrenia Research

Q1 SJR score

235

Citations

18

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

RCT

Large Human Trial

Highly Cited

Study Snapshot

Paliperidone extended-release tablets (paliperidone ER) effectively improve symptoms of schizophrenia and personal and social functioning, with a rapid onset of action and generally well-tolerated.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER): Results of a 6-week, randomized, placebo-controlled study

References

Citations